143 related articles for article (PubMed ID: 37408100)
1. The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System.
Ahn DJ; Zeng S; Pelzer KM; Barth RN; Gallo A; Parker WF
Transplantation; 2023 Oct; 107(10):e247-e256. PubMed ID: 37408100
[TBL] [Abstract][Full Text] [Related]
2. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J
Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
[TBL] [Abstract][Full Text] [Related]
4. Waiting list outcome of Peld/Meld exceptions: A single-center experience in Argentina.
Lauferman L; Dip M; Halac E; Cervio G; Aredes D; Capparelli M; Reijenstein H; Minetto J; Rojas L; Goñi J; Jacobo Dillon A; Martinitto R; Imventarza O
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29297966
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.
Chang CH; Bryce CL; Shneider BL; Yabes JG; Ren Y; Zenarosa GL; Tomko H; Donnell DM; Squires RH; Roberts MS
JAMA Pediatr; 2018 Nov; 172(11):1070-1077. PubMed ID: 30242345
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.
Swenson SM; Roberts JP; Rhee S; Perito ER
Am J Transplant; 2019 Dec; 19(12):3308-3318. PubMed ID: 31370108
[TBL] [Abstract][Full Text] [Related]
7. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
Shneider BL; Suchy FJ; Emre S
Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
[TBL] [Abstract][Full Text] [Related]
8. Waitlist mortality and post-liver transplant outcomes of pediatric patients with hepatocellular carcinoma and hepatoblastoma in the United States.
Wu WK; Ziogas IA; Matsuoka LK; Izzy M; Pai AK; Benedetti DJ; Alexopoulos SP
Pediatr Blood Cancer; 2022 Jan; 69(1):e29425. PubMed ID: 34736292
[TBL] [Abstract][Full Text] [Related]
9. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
[TBL] [Abstract][Full Text] [Related]
10. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
[TBL] [Abstract][Full Text] [Related]
11. A model including standardized weight improved predicting waiting list mortality in adolescent liver transplant candidates: A US national study.
Shaheen AA; Martin SR; Khorsheed S; Abraldes JG
Liver Transpl; 2024 Mar; 30(3):269-276. PubMed ID: 37655999
[TBL] [Abstract][Full Text] [Related]
12. Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception.
Cannon RM; Davis EG; Goldberg DS; Lynch RJ; Shah MB; Locke JE; McMasters KM; Jones CM
J Am Coll Surg; 2020 Apr; 230(4):503-512.e8. PubMed ID: 32007535
[TBL] [Abstract][Full Text] [Related]
13. Renal Function Parameters and Serum Sodium Enhance Prediction of Wait-List Outcomes in Pediatric Liver Transplantation.
Thalji L; Thalji NM; Heimbach JK; Ibrahim SH; Kamath PS; Hanson A; Schulte PJ; Haile DT; Kor DJ
Hepatology; 2021 Mar; 73(3):1117-1131. PubMed ID: 32485002
[TBL] [Abstract][Full Text] [Related]
14. Improving the predictive ability of the pediatric end-stage liver disease score for young children awaiting liver transplant.
Hsu E; Schladt DP; Wey A; Perito ER; Israni AK
Am J Transplant; 2021 Jan; 21(1):222-228. PubMed ID: 32306489
[TBL] [Abstract][Full Text] [Related]
15. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
16. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
[TBL] [Abstract][Full Text] [Related]
17. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
[TBL] [Abstract][Full Text] [Related]
18. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
19. Association of high-priority exceptions with waitlist mortality among heart transplant candidates.
Johnson DY; Ahn D; Lazenby K; Zeng S; Zhang K; Narang N; Khush K; Parker WF
J Heart Lung Transplant; 2023 Sep; 42(9):1175-1182. PubMed ID: 37225029
[TBL] [Abstract][Full Text] [Related]
20. Re-weighting the model for end-stage liver disease score components.
Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS
Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
